Organigram Global (OGI) Cash from Financing Activities (2018 - 2026)

Organigram Global (OGI) posted quarterly Cash from Financing Activities of -$328.9 million for Q1 2026, down 101.16% year-on-year from $28.3 billion in Q1 2025, and down 101816.07% on a QoQ basis from -$322688.8 in Q4 2025.

Organigram Global (OGI) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Cash from Financing Activities for 7 consecutive years, with -$328.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Financing Activities fell 101.16% year-over-year to -$328.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 billion (up 226.12% YoY) and the FY2025 annual result came in at $28.6 million, down 63.83% from the prior year.
  • Cash from Financing Activities slipped to -$328.9 million in Q1 2026 per OGI's latest filing, from -$322688.8 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OGI reached as high as $28.3 billion in Q1 2025 and fell as low as -$328.9 million in Q1 2026.
  • A 3-year average of $7.0 billion and a median of -$233645.2 in 2024 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2025 — Cash from Financing Activities plunged 123.16% — and 2026, when it sank 101.16%.
  • Year by year, Cash from Financing Activities stood at -$144601.5 in 2024, then tumbled by 123.16% to -$322688.8 in 2025, then slumped by 101816.07% to -$328.9 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$328.9 million, -$322688.8, and $28.3 billion for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -328.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -328.87 Mn
Mar 31, 2026 -328.87 Mn
Dec 31, 2025 -322,688.83
Dec 31, 2025 -322,688.83
Mar 31, 2025 28.34 Bn
Mar 31, 2025 28.34 Bn
Dec 31, 2024 -144,601.53
Dec 31, 2024 -144,601.53
May 31, 2021 174.41 Mn
May 31, 2021 174.41 Mn
Feb 28, 2021 -50.72 Bn
Feb 28, 2021 -50.72 Bn
Nov 30, 2020 63.19 Bn
Nov 30, 2020 63.19 Bn
Aug 31, 2020 34.29 Mn
Aug 31, 2020 34.29 Mn
May 31, 2020 19.81 Mn
May 31, 2020 19.81 Mn
Feb 29, 2020 52.57 Mn
Feb 29, 2020 52.57 Mn